Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CDKN2A |
Variant | E69G |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | CDKN2A E69G lies within ANK repeat 2 of the Cdkn2a protein (UniProt.org). The functional effect of E69G is conflicting as it results in loss of Cdk4 and Cdk6 binding and aberrant proliferation of cells in culture (PMID: 19260062, PMID: 20340136), but inhibits proliferation and cell cycle progression to similar levels of wild-type protein in another study (PMID: 35001868), and therefore, its effect on Cdkn2a protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
CDKN2A mutant CDKN2A E69G |
Transcript | NM_000077.5 |
gDNA | chr9:g.21971153T>C |
cDNA | c.206A>G |
Protein | p.E69G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011517676 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_001195132.1 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_001363763.2 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517679 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517675.2 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517679.1 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_005251343 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_047422596.1 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517675.3 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_047422598.1 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517675 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_000077.5 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_000077 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517676.3 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_047422597.1 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_001195132.2 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_011517676.2 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
XM_005251343.1 | chr9:g.21971000T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_001195132 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
NM_000077.4 | chr9:g.21971153T>C | c.206A>G | p.E69G | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|